|
Kenneth G. Mann, Ph.D., Chairman and Professor of Biochemistry at the University of Vermont since 1984, received his Ph.D. in biochemistry at the University of Iowa and did his postdoctoral training in physical biochemistry at Duke University. He served on the faculty of both the University of Minnesota and the Mayo Clinic (Mayo Medical School) in Rochester, Minnesota before joining the faculty of the University of Vermont.
Dr. Mann began his research with a description of multiple forms of thrombin in 1968. Over 30 years later, his efforts have resulted in the detailed description of the dynamic process of blood coagulation, for which he was honored with the E. Donnall Thomas Lecture and Prize at the 2002 annual meeting of the American Society of Hematology. Dr. Mann has also been the recipient of the Stratton Medal from the American Society of Hematology, the Grant Medal from the International Society of Hemostasis and Thrombosis, and the Sherry Award from the American Heart Association. He has authored more than 417 publications and has 11 blood coagulation-related patents.
Over the course of his career, Dr. Mann has identified and described the chemical mechanisms involved in the formation of pro-coagulant complexes on membranes, the biophysical properties of pro- and anticoagulants, and their mechanisms of action. In the past 10 years, Dr. Mann’s laboratory has developed models for studying the entire blood coagulation process under physiologic conditions to provide a consistent description of the evolution and expression of thrombin activity in pro- and anticoagulant processes.
In the past Dr. Mann has served as President and Treasurer of the Association of Medical and Graduate Departments of Biochemistry; Chairman, International Society on Thrombosis and Hemostasis; Chairman, Council on Thrombosis for the American Heart Association; Publications Committee Chairman of the American Society of Hematology.
He presently serves on the Board of Directors of the National Hemophilia Foundation. Scientific Advisory Board of the Leducq Foundation and as co-Chair of the NHLBI Strategic Planning Committee for Thrombosis.
|
